Skip to main content
Tech.euFundingExplorerBeta

Midiagnostics

miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.

Midiagnostics has raised €64M across 3 funding rounds from 5 investors, most recently a Series D+ round in Dec 2024. Based in Leuven, Belgium; founded 2015; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€64M
€64,000,000
Funding rounds
3
Investors
5
distinct backers
Active since
2020-03
latest 2024-12

Funding by year

EUR raised per year
Midiagnostics — funding by year — interactive chart.
Data table
Midiagnostics — funding by year
2020€14M
2021€20M
2024€30M

Signals

High confidence
Raise-next likelihood37
base rate 53% for Series D+
  • ▼ Past typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 11y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2024-12-04Series D+€30MAlychlo,Pamica,Thermo Fisher Scientific Inc.,VMF InvestView deal →
2021-12-09Debt€20MEuropean Investment Bank (EIB)View deal →
2020-03-26Other€14M—View deal →

Similar companies

same sector or country

Global coverage: FundingData